 Pharmacokinetics ganciclovir patient undergoing hemodialysis pharmacokinetics effect hemodialysis clearance ganciclovir patient cytomegalovirus CMV retinitis pneumonitis dialytic support dose mg ganciclovir mg/kg intravenous infusion period Blood samples next hours plasma ganciclovir concentrations patient underwent hemodialysis following day arterial venous blood samples dialyzer clearance antiviral agent High-performance liquid chromatography ganciclovir plasma concentrations Ganciclovir levels monoexponential manner infusion prior patient peak ganciclovir concentration micrograms/mL peak concentrations patients normal renal function elimination half-life hours patient values patients normal renal function volume distribution L/kg total body clearance hemodialysis mL/min patient Hemodialysis ganciclovir levels extraction coefficient dialyzer clearance mL/min supplementation ganciclovir patients antiviral agent hemodialysis close monitoring ganciclovir concentrations patients abnormal renal function necessary order appropriate dosage adjustments